| Product NDC: | 50268-467 |
| Proprietary Name: | Levetiracetam |
| Non Proprietary Name: | Levetiracetam |
| Active Ingredient(s): | 250 mg/1 & nbsp; Levetiracetam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50268-467 |
| Labeler Name: | AvPAK |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077319 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090320 |
| Package NDC: | 50268-467-11 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (50268-467-11) |
| NDC Code | 50268-467-11 |
| Proprietary Name | Levetiracetam |
| Package Description | 100 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (50268-467-11) |
| Product NDC | 50268-467 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levetiracetam |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090320 |
| Marketing Category Name | ANDA |
| Labeler Name | AvPAK |
| Substance Name | LEVETIRACETAM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |